U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2011
587
Substance Class Protein
Created
by admin
on Mon Mar 31 18:50:49 GMT 2025
Edited
by admin
on Mon Mar 31 18:50:49 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
15C2VL427D
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
Aflibercept
DASH   INN   MART.   MI   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
AFLIBERCEPT (GENETICAL RECOMBINATION)
JAN  
Preferred Name English
AFLIBERCEPT [VANDF]
Common Name English
BAY-865321
Code English
AFLIBERCEPT [MI]
Common Name English
AFLIBERCEPT [USAN]
Common Name English
BAY-86-5321
Code English
AFLIBERCEPT (GENETICAL RECOMBINATION) [JAN]
Common Name English
AFLIBERCEPT [JAN]
Common Name English
EYLEA HD
Brand Name English
AFLIBERCEPT [PURPLE BOOK CDER]
Common Name English
AVE-0005
Code English
AFLIBERCEPT [MART.]
Common Name English
VEGF TRAP-EYE
Common Name English
BAY86-5321
Code English
aflibercept [INN]
Common Name English
EYLEA
Brand Name English
Aflibercept [WHO-DD]
Common Name English
AVE0005
Code English
VEGF TRAP
Code English
AFLIBERCEPT RECOMBINANT
Common Name English
Aflibercept beta [WHO-DD]
Common Name English
Classification Tree Code System Code
WHO-ATC S01LA05
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
EMA ASSESSMENT REPORTS EYLEA (AUTHORIZED: WET MACULAR DEGENERATION)
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
WHO-VATC QS01LA05
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
NDF-RT N0000193543
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
EMA ASSESSMENT REPORTS ZALTRAP (AUTHORIZED: COLORECTAL NEOPLASMS)
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
EMA ASSESSMENT REPORTS EYLEA (AUTHORIZED: MACULAR EDEMA)
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
WHO-ATC L01XX44
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
WHO-VATC QL01XX44
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
FDA ORPHAN DRUG 694319
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
Code System Code Type Description
CAS
862111-32-8
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
RXCUI
1232150
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
ALTERNATIVE
DAILYMED
15C2VL427D
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
USAN
TT-140
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
FDA UNII
15C2VL427D
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
IUPHAR
6786
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
MESH
C533178
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
INN
8739
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
EVMPD
SUB26987
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
DRUG BANK
DB08885
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
JAPANESE REVIEW
EYLEA
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY APPROVED JUNE 2015
ChEMBL
CHEMBL1742982
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
SMS_ID
100000091493
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
MERCK INDEX
m1444
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY Merck Index
NCI_THESAURUS
C2682
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
RXCUI
1304475
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
DRUG CENTRAL
4916
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
LACTMED
Aflibercept
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
WIKIPEDIA
AFLIBERCEPT
Created by admin on Mon Mar 31 18:50:49 GMT 2025 , Edited by admin on Mon Mar 31 18:50:49 GMT 2025
PRIMARY
From To
1_30 1_79
2_30 2_79
1_124 1_185
2_124 2_185
1_211 2_211
1_214 2_214
1_246 1_306
2_246 2_306
1_352 1_410
2_352 2_410
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_36
N 1_68
N 1_123
N 1_196
N 1_282
N 2_36
N 2_68
N 2_123
N 2_196
N 2_282
O 1_33
O 2_33
Related Record Type Details
AFLIBERCEPT BIOSIMILAR (LUBT-017)
SUB_CONCEPT->SUBSTANCE
Aflibercept-MRBB
SUB_CONCEPT->SUBSTANCE
Aflibercept-JBVF
SUB_CONCEPT->SUBSTANCE
HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR B
TARGET -> INHIBITOR
AFLIBERCEPT BIOSIMILAR (LUBT-017)
BIOSIMILAR -> PARENT
Aflibercept-ABZV
SUB_CONCEPT->SUBSTANCE
ZIV-AFLIBERCEPT
SUB_CONCEPT->SUBSTANCE
Aflibercept-ABZV
BIOSIMILAR -> PARENT
Aflibercept-AYYH
BIOSIMILAR -> PARENT
Aflibercept-YSZY
SUB_CONCEPT->SUBSTANCE
Aflibercept-AYYH
SUB_CONCEPT->SUBSTANCE
HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR A
TARGET -> INHIBITOR
Related Record Type Details
Aflibercept
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Molecular Formula CHEMICAL
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966